Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (39)

2024

  1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis

    Molecular Psychiatry

  2. Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter

    Journal of Affective Disorders, Vol. 351, pp. 649-660

  3. Clinical predictors and psychosocial risk factors of suicide attempt severity

    Spanish Journal of Psychiatry and Mental Health

  4. Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study

    Nutrients, Vol. 16, Núm. 2

  5. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents

    BMC psychiatry, Vol. 23, Núm. 1, pp. 178

  2. Experiences and impact on the quality of life of people with long COVID

    Gaceta Sanitaria, Vol. 37

  3. Incidence of mental disorders in the general population aged 1–30 years disaggregated by gender and socioeconomic status

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 6, pp. 961-971

  4. Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

  5. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  6. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

  7. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

    Schizophrenia, Vol. 8, Núm. 1

  2. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

    Schizophrenia, Vol. 8, Núm. 1

  3. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  4. Modelling the risk of hospital admission of lab confirmed SARS-CoV-2-infected patients in primary care: a population-based study

    Internal and emergency medicine, Vol. 17, Núm. 4, pp. 1211-1221

  5. Perceptions and experiences of 7-8 year old schoolchildren in the Basque Country during the COVID-19 health alert

    Gaceta Sanitaria, Vol. 36, Núm. 1, pp. 19-24

  6. Relevance of well-being, resilience, and health-related quality of life to mental health profiles of European adolescents: results from a cross-sectional analysis of the school-based multinational UPRIGHT project

    Social Psychiatry and Psychiatric Epidemiology, Vol. 57, Núm. 2, pp. 279-291

  7. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry, Vol. 11, Núm. 1